Jin Medical International (ZJYL) P/E (2023 - 2026)
Jin Medical International (ZJYL) P/E from Mar 28, 2023 to Jul 20, 2026. The TTM Jin Medical International (ZJYL) P/E is 13.15. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Jin Medical International (ZJYL)
| Year | P/E | Change |
|---|---|---|
| 2026 | 13.15 | -54.56% |
| 2025 | 28.94 | -12.24% |
| 2024 | 32.98 | -95.09% |
| 2023 | 671.57 | N/A |
Comparison Jin Medical International (ZJYL) P/E with competitors
Jin Medical International (ZJYL) P/E is 13.15.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -98.30% |
| EMBC | Embecta Corp | 1.69 | -87.15% |
| SOLV | Solventum Corp | 9.49 | -27.83% |
| PDEX | Pro-Dex Inc (co) | 15.22 | +15.72% |
| RMD | Resmed Inc | 19.04 | +44.81% |
| UTMD | Utah Medical Products Inc | 20.76 | +57.85% |
| ATR | Aptargroup Inc | 21.65 | +64.60% |
| ALGN | Align Technology Inc | 30.29 | +130.33% |
| HOLX | Hologic Inc | 30.86 | +134.68% |
| MMSI | Merit Medical Systems Inc | 31.15 | +136.83% |
| STVN | Stevanato Group Spa | 31.25 | +137.65% |
| LMAT | Lemaitre Vascular Inc | 36.34 | +176.33% |
| ALC | Alcon Inc | 41.51 | +215.67% |
| ISRG | Intuitive Surgical Inc | 46.43 | +253.02% |
| BDX | Becton Dickinson & Company | 46.93 | +256.86% |
| WST | West Pharmaceutical Services Inc | 47.41 | +260.48% |
| NEPH | Nephros Inc | 50.00 | +280.16% |
| COO | Cooper Companies Inc | 58.98 | +348.46% |
| NNNN | Anbio Biotechnology - Class A | 62.20 | +372.95% |
| NVST | Envista Holdings Corp | 64.66 | +391.69% |
| BAX | Baxter International Inc | 72.66 | +452.46% |
| ICUI | ICU Medical Inc | 84.82 | +544.96% |
| RGEN | Repligen Corp | 162.20 | +1133.31% |
| WRBY | Warby Parker Inc - Class A | 318.30 | +2320.28% |